Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA072686 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA072686, RRID:AB_2732209
- Product name
- Anti-TBX19
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human TBX19, Gene description: T-box 19, Alternative Gene Names: dj747L4.1, TPIT, Validated applications: IHC, Uniprot ID: O60806, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI
Genome-wide DNA Methylation Differences in Nonfunctioning Pituitary Adenomas With and Without Postsurgical Progression
The genomic profiling and MAMLD1 expression in human and canines with Cushing’s disease
MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes
TGFBR3L—An Uncharacterised Pituitary Specific Membrane Protein Detected in the Gonadotroph Cells in Non-Neoplastic and Tumour Tissue
Pituispheres Contain Genetic Variants Characteristic to Pituitary Adenoma Tumor Tissue
A specific antibody to detect transcription factor T-Pit: a reliable marker of corticotroph cell differentiation and a tool to improve the classification of pituitary neuroendocrine tumours
Amano T, Masumoto T, Watanabe D, Hoshiai S, Mori K, Sakamoto N, Kino H, Akutsu H, Nakajima T
Japanese Journal of Radiology 2023;41(9):938-946
Japanese Journal of Radiology 2023;41(9):938-946
Genome-wide DNA Methylation Differences in Nonfunctioning Pituitary Adenomas With and Without Postsurgical Progression
Hallén T, Johannsson G, Dahlén R, Glad C, Örndal C, Engvall A, Carén H, Skoglund T, Olsson D
The Journal of Clinical Endocrinology & Metabolism 2022;107(8):2318-2328
The Journal of Clinical Endocrinology & Metabolism 2022;107(8):2318-2328
The genomic profiling and MAMLD1 expression in human and canines with Cushing’s disease
Wang A, Neill S, Newman S, Tryfonidou M, Ioachimescu A, Rossi M, Meij B, Oyesiku N
BMC Endocrine Disorders 2021;21(1)
BMC Endocrine Disorders 2021;21(1)
MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes
Uraki S, Ariyasu H, Doi A, Takeshima K, Morita S, Inaba H, Furuta H, Fukuhara N, Inoshita N, Nishioka H, Nakao N, Yamada S, Akamizu T
International Journal of Molecular Sciences 2020;21(8):2831
International Journal of Molecular Sciences 2020;21(8):2831
TGFBR3L—An Uncharacterised Pituitary Specific Membrane Protein Detected in the Gonadotroph Cells in Non-Neoplastic and Tumour Tissue
Sjöstedt E, Kolnes A, Olarescu N, Mitsios N, Hikmet F, Sivertsson Å, Lindskog C, Øystese K, Jørgensen A, Bollerslev J, Casar-Borota O
Cancers 2020;13(1):114
Cancers 2020;13(1):114
Pituispheres Contain Genetic Variants Characteristic to Pituitary Adenoma Tumor Tissue
Peculis R, Mandrika I, Petrovska R, Dortane R, Megnis K, Nazarovs J, Balcere I, Stukens J, Konrade I, Pirags V, Klovins J, Rovite V
Frontiers in Endocrinology 2020;11
Frontiers in Endocrinology 2020;11
A specific antibody to detect transcription factor T-Pit: a reliable marker of corticotroph cell differentiation and a tool to improve the classification of pituitary neuroendocrine tumours
Sjöstedt E, Bollerslev J, Mulder J, Lindskog C, Pontén F, Casar-Borota O
Acta Neuropathologica 2017;134(4):675-677
Acta Neuropathologica 2017;134(4):675-677
No comments: Submit comment
No validations: Submit validation data